To view or add a comment, sign in PCSK9 inhibitors and lipoprotein(a): what really happens in real-world practice This large, multi-centre real-world study published in the European Journal of Preventive Cardiology evaluates how PCSK9 inhibitors (PCSK9i) affect lipoprotein(a) [Lp(a)] levels outside randomized trialsand which patients benefit most
Safety of Combining Semaglutide and Bupropion No major drug-drug interaction between semaglutide and bupropion has been documented in clinical literature, and both are metabolized through different pathways
As all people with diabetes are at high risk of CVD, HF and CKD over time, real-world evidence and cost-effectiveness studies of GLP-1 RA and SGLT2i in broad populations would help to better target interventions to have the greatest impact on outcomes
Dehydration Lower fluid intake, nausea, or vomiting can all contribute to tiredness
This cardiovascular benefit reflects weight loss, improved glucose control, and direct effects on vascular function
